Back
Catalyst Pharmaceuticals Vs. Manhattan Associates Industry Stock Comparison
Buy
55
CPRX
Catalyst Pharmaceuticals
Last Price:
16.50
Seasonality Move:
16.98%
Buy
57
MANH
Manhattan Associates
Last Price:
228.69
Seasonality Move:
6.31%
Buy
55
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $16.49. The Score for CPRX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Manhattan Associates (MANH)
is a Buy
Is Manhattan Associates a Buy, Sell or Hold?
- The current Manhattan Associates [MANH] share price is $228.78. The Score for MANH is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- MANH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $16.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight selling pressure.
MANH Stock Price Chart
What is Manhattan Associates's stock price today?
-
The Manhattan Associates share price today is $228.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MANH is experiencing slight buying pressure.
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 61.13 | Buy |
| Chaikin Money Flow: | -382725 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.82 - 16.04) | Buy |
| Bollinger Bands (100): | (14.24 - 16.32) | Buy |
MANH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.22 | Sell |
| Relative Strength Index (14 RSI): | 58.04 | Buy |
| Chaikin Money Flow: | 154990 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (209.61 - 227.23) | Buy |
| Bollinger Bands (100): | (215.08 - 250.32) | Sell |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.07 | Buy |
| 20-day SMA: | 15.42 | Buy |
| 50-day SMA: | 15.68 | Buy |
| 200-day SMA: | 14.37 | Buy |
| 8-day EMA: | 16.14 | Buy |
| 20-day EMA: | 15.73 | Buy |
| 50-day EMA: | 15.49 | Buy |
| 200-day EMA: | 14.73 | Buy |
MANH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 219.73 | Buy |
| 20-day SMA: | 215.69 | Buy |
| 50-day SMA: | 232.88 | Sell |
| 200-day SMA: | 218.63 | Buy |
| 8-day EMA: | 221.13 | Buy |
| 20-day EMA: | 220.49 | Buy |
| 50-day EMA: | 227.23 | Buy |
| 200-day EMA: | 217.07 | Buy |
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.14 per share, and an increase next year of $0.20 per share.
Manhattan Associates Earnings Growth & MANH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.10 per share, an increase this year of $0.39 per share, and an increase next year of $0.51 per share.
Catalyst Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Manhattan Associates Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||